285
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Antioxidant potential of all-trans retinoic acid (ATRA) and enhanced activity of liposome encapsulated ATRA against inflammation and tumor-directed angiogenesis

&
Pages 164-173 | Received 11 Jun 2012, Accepted 28 Sep 2012, Published online: 02 Nov 2012

References

  • Cerutti, P.A. Oxidant stress and carcinogenesis. Eur J Clin Invest 1991, 21, 1–5.
  • Bondarenko, V.M., Vinogradov, N.A., Maleev, V.V. The antimicrobial activity of nitric oxide and its role in the infectious process. Zh Mikrobiol Epidemiol Immunobiol 1999, 5, 61–67.
  • Krishnamoorthy, S., Honn, K.V. Inflammation and disease progression. Cancer Metastasis Rev 2006, 25, 481–491.
  • Dedon, P.C., Tannenbaum, S.R. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004, 423, 12–22.
  • Coussens, L.M., Werb, Z. Inflammation and cancer. Nature 2002, 420, 860–867.
  • Surh, Y.J. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr 2008, 17, 269.
  • Gupta SS. Prospects and perspectives of natural plants products in medicine. Indian J Pharmacol 1994, 26, 1.
  • Cerutti, P.A. Oxy-radicals and cancer. Lancet 1994, 344, 862–863.
  • Ames, B.N., Gold, L.S., Willet, W.C. The causes and prevention of cancer. Proc Natl Acad Sci USA 1995, 92, 5258–5265.
  • Siddikuzzaman, Guruvayoorappan, C., Berlin Grace, V.M. All trans-retinoic acid and cancer. Immunopharmacol Immunotoxicol 2011, 33, 241–249.
  • Mark, M., Ghyselinck, N.B., Chambon, P. Retinoic acid signalling in the development of branchial arches. Curr Opin Genet Dev 2004, 14, 591–598.
  • Lefebvre, P. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities. Curr Drug Targets Immune Endocr Metabol Disord 2001, 1, 153–164.
  • DiSepio, D., Malhotra, M., Chandraratna, R.A., Nagpal, S. Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker. J Biol Chem 1997, 272, 25555–25559.
  • Ozpolat, B., Lopez-Berestein, G., Adamson, P., Fu, C.J., Williams, A.H. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers. J Pharm Pharm Sci 2003, 6, 292–301.
  • Choi, Y., Kim, S.Y., Kim, S.H., Yang, J., Park, K., Byun, Y. Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer 2003, 107, 145–148.
  • Labhasetwar, V., Song, C., Levy, R.J. Nanoparticle drug delivery system for restenosis. Adv Drug Deliv Rev 1997, 24, 63–85.
  • Philip, M., Rowley, D.A., Schreiber, H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 2004, 14, 433–439.
  • Copstead, LE, Banaski, JL. (2000). Pathophysiology: biological and behavioral perspectives, 2nd edition. Philadelphia: W.B. Saunders, 210–223.
  • Akiko, S, Akira, S, Akira, U, Masataka, K, Hiroyuki, K., Yasufumi, S., Yuji, O., Hisatake, K., Mayumi, S., Masahiko, K., Masue, I., Shigeru, T., Sadayoshi, I. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 2007, 148, 1412–1423.
  • Blebea, J., Vu, J.H., Assadnia, S., McLaughlin, P.J., Atnip, R.G., Zagon, I.S. Differential effects of vascular growth factors on arterial and venous angiogenesis. J Vasc Surg 2002, 35, 532–538.
  • Arsenou, E.S., Papadimitriou, E.P., Kliafa, E., Hountala, M., Nikolaropoulos, S.S. Effects of retinoic acid steroidal analogs on human leukemic HL60 cell proliferation in vitro and on angiogenesis in vivo. Anticancer Drugs 2005, 16, 151–158.
  • Bhowmick, S., Ali, N. Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis. PLoS ONE 2009, 4, e5820.
  • Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S., Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126, 131–138.
  • Marcocci, L., Maguire, J.J., Droy-Lefaix, M.T., Packer, L. The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 1994, 201, 748–755.
  • McCord, J.M., Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969, 244, 6049–6055.
  • Halliwell, B., Gutteridge, J.M., Aruoma, O.I. The deoxyribose method: a simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem 1987, 165, 215–219.
  • Ohkawa, H., Ohishi, N., Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95, 351–358.
  • Winter, C., Risley, E., Nuss, O. Carrageenininduced inflammation in the hind limb of the rat. Fed Proc 1962, 46, 118–126.
  • Jain, P., Khanna, N.K. Evaluation of anti-inflammatory and analgesic properties of L-glutamine. Agents Actions 1981, 11, 243–249.
  • Booran, G.A., Eustis, S.L., Elwell, M.R., Montgory, C.A., MaKenzie, W.F. (1990). Pathology of the fisher rat. San Diego: Academic Press, 405–418.
  • Cole, S.P. Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. Cancer Chemother Pharmacol 1986, 17, 259–263.
  • Campling, B.G., Pym, J., Baker, H.M., Cole, S.P., Lam, Y.M. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer 1991, 63, 75–83.
  • Leyon, P.V., Kuttan, G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res 2003, 22, 77–83.
  • Kishi, K., Petersen, S., Petersen, C., Hunter, N., Mason, K., Masferrer, J.L., Tofilon, P.J., Milas, L. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 2000, 60, 1326–1331.
  • Semple, S.C., Chonn, A., Cullis, P.R. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 1996, 35, 2521–2525.
  • Murao, A., Nishikawa, M., Managit, C., Wong, J., Kawakami, S., Yamashita, F., Hashida, M. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition. Pharm Res 2002, 19, 1808–1814.
  • Teshima, M., Kawakami, S., Nishida, K., Nakamura, J., Sakaeda, T., Terazono, H., Kitahara, T., Nakashima, M., Sasaki, H. Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. J Control Release 2004, 97, 211–218.
  • Shinmoto, H., Dosako, S., Nakajima, I. Antioxidant activity of bovine lactoferrineon iron/ ascorbate induced lipid peroxidation. Biosci Biotech Biochem 1992, 56, 2079–2080.
  • Dirosa, M., Giround, J.P., Willoughby, D.A. Studies of the mediators of acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 1971, 104, 15–29.
  • Heller, A., Koch, T., Schmeck, J., van Ackern, K. Lipid mediators in inflammatory disorders. Drugs 1998, 55, 487–496.
  • Williams, T.J., Morley, J. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973, 246, 215–217.
  • White, M. Mediators of inflammation and the inflammatory process. J Allergy Clin Immunol 1999, 103, S378–S381.
  • Tjølsen, A., Berge, O.G., Hunskaar, S., Rosland, J.H., Hole, K. The formalin test: an evaluation of the method. Pain 1992, 51, 5–17.
  • Iles, K.E., Forman, H.J. Macrophage signaling and respiratory burst. Immunol Res 2002, 26, 95–105.
  • Kundu, J.K., Surh, Y.J. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. Mutat Res 2005, 591, 123–146.
  • Berlin Grace, V.M., Niranjali Devaraj, S., Radhakrishnan Pillai, M., Devaraj, H. HPV-induced carcinogenesis of the uterine cervix is associated with reduced serum ATRA level. Gynecol Oncol 2006, 103, 113–119.
  • Gourley, M., Williamson, J.S. Angiogenesis: new targets for the development of anticancer chemotherapies. Curr Pharm Des 2000, 6, 417–439.
  • Hanahan, D., Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86, 353–364.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.